• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Researchers discover external protein network can help stabilize neural connections

News
Article

The study, conducted by the National Eye Institute and University of Freiberg, Germany, sheds light on nerve function in the brain and retina.

(Image Credit: AdobeStock/ustas)

(Image Credit: AdobeStock/ustas)

The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons, according to a study in mice from the National Eye Institute (NEI) and the University of Freiberg, Germany.

According to an NEI news release, without this external, stabilizing protein network, the AMPA receptors are no longer retained at the synapse, leading to weak, short-lived synaptic signals. The findings not only provide insight into processes such as learning and memory but also the development of blinding conditions like glaucoma.

The study1 was published in the journal Neuron. NEI is part of the National Institutes of Health.

“This study shows that Noelins have a crucial job in supporting synapse function in the brain and other neural tissues like the eye’s retina,” Stanislav Tomarev, PhD, chief of NEI’s Section on Retinal Ganglion Cell Biology and co-senior author of the report, said in the news release.

According to the news release, neurons pass signals from one cell to the next via synapses, specialized connection points between the two cells. The main excitatory synapses in the brain are glutamatergic, meaning that they use the chemical messenger glutamate to transmit their signals across the synapse.

The presynaptic “sending” cell emits glutamate, which travels across the synaptic cleft and is sensed by glutamate receptors on the postsynaptic “receiving” cell. These glutamate receptors are ion channels; when the channels sense glutamate, they open, generating a new neuronal signal within the postsynaptic cell. In order to generate a strong signal, sufficient receptors must be present in the correct location of the cell’s surface at the synapse.1

Moreover, the researchers, led by Tomarev and Bernd Fakler, MD, University of Freiberg, used biochemical and genetic methods to explore the complex network of extracellular proteins maintaining the localization of AMPA-type glutamate receptors at neural synapses, according to the news release.

Schematic of synapses with and without Noelins. On the left, Noelin proteins anchor the AMPA glutamate receptor and other associated proteins to the synapse and other regions of the nerve cell. On the right, without Noelins, the concentration of AMPA glutamate receptors at the synapse is reduced, and associated proteins are missing. (Image courtesy of Stanislav Tomarev/NEI)

Schematic of synapses with and without Noelins. On the left, Noelin proteins anchor the AMPA glutamate receptor and other associated proteins to the synapse and other regions of the nerve cell. On the right, without Noelins, the concentration of AMPA glutamate receptors at the synapse is reduced, and associated proteins are missing. (Image courtesy of Stanislav Tomarev/NEI)

The research team first took mouse brain tissue, and isolated cellular membranes and their attached proteins. Using mass spectroscopy and specialized analytic techniques, the team worked out which proteins were associating with AMPA receptors in these membranes.1

The Noelin family of proteins (primarily Noelin 1, but also Noelins 2 and 3, also known as Olfactomedins 1, 2, and 3, respectively), were strongly associated with the AMPA receptors. The researchers also found secreted and membrane-anchored proteins like Neuritin and Brorin, which are known to be present at synapses.1

According to the news release, to better understand how the Noelins help regulate neuronal activity, the researchers developed mice lacking all three Noelin proteins. Without Noelins present, synapses in the mouse hippocampus had many fewer AMPA glutamate receptors. And when the researchers attempted to stimulate neurons lacking Noelins, the neuronal signals were much lower than normal.

However, the neuronal signals weren’t just lower. The researchers noted that one of the key steps in memory formation is long-term neuron signaling, also known as long-term potentiation. The scientists pointed out this is achieved through recruitment and stabilization of additional glutamate receptors at the synapse over time, leading to a sustained signal through the neuron. In the brains of mice lacking Noelins, this stabilization didn’t take place, meaning that not only were the neural signals low, they were short-lived as well.

“While this first study showed the Noelins’ role in the brain, these proteins are highly prevalent in the retina as well,” Tomarev said in the news release. “Our next task is to understand how changes in these secreted protein networks contribute to the development of retinal disorders, including glaucoma.”

According to the news release, the study was funded by the German Research Foundation and the National Eye Institute Intramural Program. Sami Boudkkazi, Jochen Schwenk and Naoki Nakaya shared lead authorship of the study.

Reference:
  1. Boudkkazi S, Schwenk J, Nakaya N, Brechet A, Kollewe A, Harada H, Bildl W, Kulik A, Dong L, Sultana A, Zolles G, Schulte U, Tomarev S, and Fakler B. “A Noelin-organized extracellular network of proteins required for constitutive and context-dependent anchoring of AMPA-receptors.” Neuron. August 16, 2023.
Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
© 2024 MJH Life Sciences

All rights reserved.